We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We may also share information about your use of our site with our social media, advertising and analytics partners. Read more about our Privacy Policy.

I got it!

3rd Antibody Drug Conjugates (ADC) Summit: From Target to Therapeutics

17-18 May 2018


This premier B2B event provides the appropriate platform to engage and discuss ideas with your fellow peers while facilitating a professional atmosphere and environment for good company representation and development.

The summit will shed light on:

 

DISCOVERY, DEVELOPMENT & BIOANALYTICAL STRATEGIES TOWARDS NEXT GENERATION ADC:

• Better understandable, more precise and new targets

• Alternative scaffolds and new payloads

• Optimized conjugation chemistry and stability

• Improved therapeutic index

 

SUCCESSFUL TRANSLATION INTO CLINIC & CLINICAL PROGRESS:

•ADC to treat tumors of the hematopoietic and lymphoid tissues

•ADC to treat solid tumors

•ADC to treat non-oncology diseases

•ADC - immuno-oncology combinations

• Bispecific

When

17 May 2018 @ 09:00 am

18 May 2018 @ 06:00 pm

Duration: 1 days, 9 hours


Where

Hotel Novotel Barcelona City

201 Avinguda Diagonal

08018 Barcelona

Spain


Organised by

Vonlanthen Group

Premium Events in Health

Recent Publications in Health

Recent Videos in Health

Recent News in Health

#EUVaccines #VaccinesWork https://t.co/n9ioUCC5yP

@EU_Health - 22 Jan 2019 17:44

The third #influenza virus characterisation report of the 2018-19 #flu season is now online. As of week 1/2019, 18… https://t.co/6fNxMlV6oo

@ECDC_EU - 22 Jan 2019 16:24

There are signs, Ben Cooper writes, that scepticism in the investment community about food companies' moves on sustainability is starting to ease.

@https://www.just-food.com/analysis/how-do-investors-view-company-moves-on-sustainability_id140806.aspx?utm_source=article-feed&utm_medium=rss-feed&utm_campaign=rss-feed - 22 Jan 2019 13:51

Recent Speakers in Health

Premium Eventslearn more ..